Yuxiang Liang - Concepedia

Author

Yuxiang Liang

Also Known As

Liang Y, Liang,Yingke, Liang,Yuxiang, Y. Liang, Y.-K. Liang, YU-XIANG LIANG, Yongyu Liang, Yu-Xiang Liang, Yu-xiang Liang, YuXiang Liang

110

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Guangzhou Medical University Guangzhou First People's Hospital Southern Medical University First Affiliated Hospital of Guangzhou Medical University Key Laboratory of Guangdong Province

About

Yuxiang Liang is an author at Guangzhou Medical University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	991
2	Engineering	2	2	47
3	Health Sciences	2	2	44
4	Natural Sciences	1	1	22
5	Applied Physiology	1	1	32

Yuxiang Liang

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer Chao Cai, Qing-Biao Chen, Zhaodong Han, Clinical Cancer Research	2015	152
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer Weide Zhong, Xin Fu, Guo Chen, OncoTargets and Therapy UrologyPoor OutcomeMedicineTumor GrowthBub1b Contributes	2016	120
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 Zhuoyuan Lin, Yaqiang Huang, Yanqiong Zhang, International Journal of Cancer Pca Cell ProliferationSystems BiologyUrologyCancer GenomicsPca Prognosis	2013	110
RETRACTED ARTICLE: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer Zhuoyuan Lin, Guo Chen, Yanqiong Zhang, Molecular Cancer	2017	106
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer Weide Zhong, Zhaodong Han, Huichan He, Oncology	2008	104
The high concentration of progesterone is harmful for endometrial receptivity and decidualization Yuxiang Liang, Li Liu, Jin Zhi-yong, Scientific Reports	2018	95
Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome Yuan Xue, Piotr Religa, Renhai Cao, Proceedings of the National Academy of Sciences ImmunologyPathologyTumor BiologyAngiogenesisOncology	2008	74
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer Yaqiang Huang, Zhaodong Han, Yuxiang Liang, Medical Oncology UrologyGenitourinary CancerMedicineCancer BiologyProstatic Disease	2013	67
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer Yuxiang Liang, Jianming Lü, Rujun Mo, International Journal of Oncology OncologyMedicineTumor GrowthRadical ProstatectomyCancer Genomics	2016	58
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer Yanru Zeng, Zhaodong Han, Cong Wang, BMC Urology	2015	55

Page 1